CN102552619B - Medicine for treating tumor and preparation method thereof - Google Patents
Medicine for treating tumor and preparation method thereof Download PDFInfo
- Publication number
- CN102552619B CN102552619B CN2012100123303A CN201210012330A CN102552619B CN 102552619 B CN102552619 B CN 102552619B CN 2012100123303 A CN2012100123303 A CN 2012100123303A CN 201210012330 A CN201210012330 A CN 201210012330A CN 102552619 B CN102552619 B CN 102552619B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- tumor
- treatment
- moschus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 239
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 179
- 229940079593 drug Drugs 0.000 title claims abstract description 114
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 60
- 239000002775 capsule Substances 0.000 claims abstract description 53
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 48
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 48
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 48
- 235000011837 pasties Nutrition 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 5
- 238000011282 treatment Methods 0.000 claims description 145
- 241000222336 Ganoderma Species 0.000 claims description 58
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 50
- 241000283956 Manis Species 0.000 claims description 48
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 42
- 239000000203 mixture Substances 0.000 claims description 17
- 241000628997 Flos Species 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 60
- 239000008280 blood Substances 0.000 abstract description 60
- 230000000694 effects Effects 0.000 abstract description 55
- 230000001737 promoting effect Effects 0.000 abstract description 37
- 231100000614 poison Toxicity 0.000 abstract description 25
- 230000017531 blood circulation Effects 0.000 abstract description 21
- 201000011510 cancer Diseases 0.000 abstract description 16
- 230000006870 function Effects 0.000 abstract description 11
- 239000002574 poison Substances 0.000 abstract description 7
- 230000001105 regulatory effect Effects 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000002147 killing effect Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000009835 boiling Methods 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 241000402754 Erythranthe moschata Species 0.000 abstract 2
- 241000282806 Rhinoceros Species 0.000 abstract 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 235000016854 Cyperus rotundus Nutrition 0.000 abstract 1
- 240000008397 Ganoderma lucidum Species 0.000 abstract 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 1
- 241000244365 Ligusticum sinense Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 238000003801 milling Methods 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 35
- 208000002193 Pain Diseases 0.000 description 30
- 210000000952 spleen Anatomy 0.000 description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 23
- 201000010099 disease Diseases 0.000 description 20
- 230000001225 therapeutic effect Effects 0.000 description 20
- 210000002216 heart Anatomy 0.000 description 16
- 235000012054 meals Nutrition 0.000 description 16
- 210000002784 stomach Anatomy 0.000 description 13
- 230000004087 circulation Effects 0.000 description 12
- 230000003203 everyday effect Effects 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 12
- 238000001959 radiotherapy Methods 0.000 description 11
- 239000003440 toxic substance Substances 0.000 description 11
- 206010019233 Headaches Diseases 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 206010042674 Swelling Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 231100000869 headache Toxicity 0.000 description 9
- 230000007096 poisonous effect Effects 0.000 description 9
- 206010018338 Glioma Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 238000002512 chemotherapy Methods 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 208000029312 Muscular tumor Diseases 0.000 description 7
- 230000002159 abnormal effect Effects 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- 208000032612 Glial tumor Diseases 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000033809 Suppuration Diseases 0.000 description 5
- 208000019790 abdominal distention Diseases 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 230000001174 ascending effect Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000005311 nuclear magnetism Effects 0.000 description 5
- 210000000582 semen Anatomy 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 208000002699 Digestive System Neoplasms Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 206010046798 Uterine leiomyoma Diseases 0.000 description 4
- 239000000812 cholinergic antagonist Substances 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 210000003238 esophagus Anatomy 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 201000000849 skin cancer Diseases 0.000 description 4
- 201000008261 skin carcinoma Diseases 0.000 description 4
- 230000002048 spasmolytic effect Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 201000005619 esophageal carcinoma Diseases 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 206010017758 gastric cancer Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 241000255791 Bombyx Species 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241001057584 Myrrha Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 208000024756 faint Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 241001290610 Abildgaardia Species 0.000 description 1
- 244000235603 Acacia catechu Species 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000003014 Bites and Stings Diseases 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000660877 Coridius Species 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019637 Hepatic atrophy Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000019468 Iatrogenic Disease Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010027457 Metastases to liver Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- HCOLPNRPCMFHOH-UHFFFAOYSA-N Prodigiosin Natural products CCCCCC1C=C(C=C/2N=C(C=C2OC)c3ccc[nH]3)N=C1C HCOLPNRPCMFHOH-UHFFFAOYSA-N 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 241001520094 Uroctea Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000004637 gastric cardia carcinoma Diseases 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000005980 lung dysfunction Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 208000022766 lymph node neoplasm Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000025661 ovarian cyst Diseases 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- TWFGRJUTAULJPZ-USZBIXTISA-N prodigiosin Chemical compound N1=C(C)C(CCCCC)=C\C1=C/C1=NC(C=2[N]C=CC=2)=C[C]1OC TWFGRJUTAULJPZ-USZBIXTISA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 208000013076 thyroid tumor Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating a tumor and a preparation method thereof. The medicine for treating the tumor is mainly prepared from the following raw medicines in parts by weight: 200-250 parts of prepared pangolin, 180-250 parts of Poria cocos, 80-100 parts of Ligusticum chuanxiong, 100-150 parts of white paeony root, 60-120 parts of Angelica sinensis, 10-12 parts of toad cake, 3-5 parts of rhinoceros horn, 3-5 parts of musk, 180-220 parts of ganoderma lucidum spore powder, 30-40 parts of agilawood, 80-120 parts of Cyperus rotundus and 2000-2500 parts of lotus leaf dew. The preparation method of the medicine comprises the following steps of: adding the toad cake, the rhinoceros horn and the musk into the lotus leaf dew and mixing, milling and airing to obtain an aired medicine; and then, mixing the other raw medicines and adding water; boiling, and mixing and concentrating the boiled medicine liquid to a pasty medicine; and finally, adding the pasty medicine into the aired medicine, mixing and airing, and adding the medicine into a capsule. The medicine disclosed by the invention has the functions of supplementing qi and blood, regulating yin and yang, promoting blood circulation and removing blood stasis, combating poison with poison, improving the immunity of an organism, and killing cancer cells and inhibiting the cancer cells from being reproduced. By utilizing the medicine disclosed by the invention to treat the various tumors, the treating effect is obvious and the total effective rate is more than 90%; and the medicine has the advantages of small side effects and low cost.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of medicine for the treatment of tumor and preparation method thereof.
Background technology
Tumor is that the lump or the particularity pathological changes that form paraplasm appears and in the human local tissue cell, and it can be divided into benign tumor and malignant tumor; Tumor disease is puzzle these years medical circle and unsolved a great problem always, millions of people is arranged because of tumor disease death every year, occupies the anteposition because of the disease death number, and it seriously affects the development of the mankind's life and health and national economy.
At present, doctor trained in Western medicine is adopting chemotherapy, radiotherapy and three kinds of methods of operation aspect the treatment tumor usually, wherein, operative treatment is the means of topical therapeutic, postoperative easy recurrence, and operation is difficult for the radical cure tumor, and the side effect of radiation and chemotherapy is very large, can cause serious iatrogenic disease and sequela, even can cause the exhaustion of internal organs, its difference mainly is with harm:
One, chemotherapy is one of method of systemic treatment tumor, and side effect mainly contains destruction and the Immune Dysfunction of whole body hemopoietic system, also can cause the infringement of the internal organs such as heart, digestive function and nerve, so the side effect of chemotherapy is very large;
Two, radiotherapy is the method for topical therapeutic tumor, radiotherapy can do great damage to local normal structure, or even irreversible destruction, make the internal organs loss of function, as liver radiotherapy can cause liver cirrhosis, hepatic atrophy, pulmonary's radiotherapy can cause pulmonary fibrosis, thereby causes pulmonary dysfunction, modal have sputum discharge difficulty and respiratory function forfeiture and cause dyspnea, a series of complications such as sputum deposits in lung, pulmonary infection.Can cause damage to heart if radiotherapy involves heart, cause cardiac dysfunction, if involve the hollow organs such as stomach, intestinal, can make these internal organs losses of function.In a word, the side effect of chemotherapy and radiation is large, needs strictly, reasonably to select indication.So chemotherapy and radiation not too is applicable to the treatment of tumor, in order to avoid cause unnecessary medical consequences.
At present, adopt the medicine of Chinese traditional treatment tumor many, for example: 1, application number is " 200410018190.6 ", denomination of invention is the patent of " a kind of Chinese medicine preparation for the treatment of tumor ", and the medicine of this disclosure of the invention has the effect of attacking by capable stagnant, the blood circulation promoting and blood stasis dispelling of the wet, Xiao Disorder removing blood stasis with potent drugs of phlegm retention water, promoting the circulation of QI eliminating phlegm, warming middle-JIAO appetizing, dredging collateral, dispersing swelling and dissipating binds, heat-clearing and toxic substances removing.But effect obvious not in oncotherapy, and side effect is arranged, easy recurrence of long duration, the radical cure effect is undesirable.2, application number is " 200410058013.0 ", the patent that denomination of invention is " a kind of antitumor medicine composition ", the disclosed pharmaceutical composition of this patent mainly is comprised of crude drug such as Squama Manis, Pulvis Fumi Carbonisatus, Rhizoma Sparganii, Rhizoma Curcumae, Semen Armeniacae Amarum, Fructus Mume, Endothelium Corneum Gigeriae Galli, Sanguis Draxonis, Radix Sophorae Tonkinensis, Borax, Caulis Akebiae, Radix Et Rhizoma Rhei, Fructus Aurantii Immaturus, Semen Persicae, Semen Eutyales, Semen sojae atricolor, Olibanum, Myrrha, Semen phaseoli radiati, catechu, Os Sepiae, Lignum Aquilariae Resinatum, Rhizoma Corydalis, the Radix Aucklandiae, Cinnabaris, Pumex, Semen Sinapis Albae and Aspongopuss.Though this medicine has heat-clearing and toxic substances removing, hard masses softening and resolving, antineoplastic action, in treatment lymphadenitis, lymphoid tuberculosis, lymph tumor, nasopharyngeal carcinoma, rectal cancer, esophageal carcinoma, effect is remarkable not, and side effect is arranged.3, application number is " 200410035579.1 ", the patent of invention that denomination of invention is " lumor eliminating powder ", and the disclosed drug main of this patent will be comprised of Uroctea compatilis Koch., Bombyx Batryticatus, Bombyx bombycis, Vermilion, Fructus Jujubae, Aranea, Radix Angelicae Sinensis, Herba Violae, Myrrha etc.This medicine can be used for treating cyclomastopathy, mastitis, breast tumor, skin infection, thyroid tumor, lymph node tumor etc., but therapeutic effect not obvious, and be prone to the recurrence symptom.
In order to solve this difficult problem of tumor, people are constantly being explored and are being studied, find the pathogenic factor of tumor, sum up the scheme for the treatment of and prophylaxis of tumours, the active drug of development treatment tumor, and obtained clinically certain therapeutic effect, for the mankind prevent and treat tumor and made huge contribution.However, the therapeutic effect of existing Chinese medicine preparation still can not be satisfactory.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of medicine for the treatment of tumor and preparation method thereof.Utilize the various tumors of Drug therapy of the present invention, its therapeutic effect is remarkable, and total effective rate reaches more than 90%, and side effect is little, and cost is low.
In order to address the above problem, the technical solution used in the present invention is:
The invention provides a kind of medicine for the treatment of tumor, mean with weight portion, the drug main of described treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts, Poria, 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss, 3～5 parts of Cornu rhinocerotis, 3～5 parts, Moschus, 180～220 parts of Ganoderma spore powders, 30～40 parts of Lignum Aquilariae Resinatum, 2000～2500 parts of 80～120 parts of Rhizoma Cyperi and lotus leaf drinks are made.The medicine of the treatment tumor that this crude drug forms can effectively be treated various tumors.
A kind of medicine for the treatment of tumor, mean with weight portion, and the drug main of described treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts, Poria, 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss, 3～5 parts of Cornu rhinocerotis, 3～5 parts, Moschus, 180～220 parts of Ganoderma spore powders, 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi, 60～100 parts of Herba Solani Nigris, 2000～2500 parts of 30～50 parts of xyloid stem of Flos Helianthi and lotus leaf drinks are made.The drug main of the treatment tumor that this crude drug forms will be used for the treatment of cerebroma.
A kind of medicine for the treatment of tumor, mean with weight portion, and the drug main of described treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts, Poria, 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss, 3～5 parts of Cornu rhinocerotis, 3～5 parts, Moschus, 180～220 parts of Ganoderma spore powders, 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi, 2000～2500 parts of 80～120 parts of Herba Scutellariae Barbataes and lotus leaf drinks are made.The drug main of the treatment tumor that this crude drug forms will be used for the treatment of the digestive system tumors such as liver, stomach, esophagus.
A kind of medicine for the treatment of tumor, mean with weight portion, and the drug main of described treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts, Poria, 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss, 3～5 parts of Cornu rhinocerotis, 3～5 parts, Moschus, 180～220 parts of Ganoderma spore powders, 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi, 2000～2500 parts of 100～150 parts of JIANZHONGXIAO and lotus leaf drinks are made.The drug main of the treatment tumor that this crude drug forms will be used for the treatment of hysteromyoma, ovarian cyst tumor.
A kind of medicine for the treatment of tumor, mean with weight portion, and the drug main of described treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts, Poria, 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss, 3～5 parts of Cornu rhinocerotis, 3～5 parts, Moschus, 180～220 parts of Ganoderma spore powders, 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi, 3 of animal spleen are made with 2000～2500 parts of lotus leaf drinks.The drug main of the treatment tumor that this crude drug forms will be used for the treatment of skin carcinoma.
According to the medicine of the described treatment tumor of above-mentioned any one, the dosage form of the medicine of described treatment tumor is capsule.
Medicine according to above-mentioned treatment tumor, is characterized in that, the preparation method of described capsule is:
A, at first the crude drug proportioning ratio according to the described medicine for treating tumor thing of above-mentioned any one takes various crude drug;
B, crude drug Venenum Bufonis, Cornu rhinocerotis and the Moschus taken added in lotus leaf drink and carry out mixed grinding, grind and make emulsus, then it is air-dry to add the crude drug Ganoderma spore powder to carry out, obtain air-dry medicine after air-dry stand-by;
C, other crude drug except Venenum Bufonis, Cornu rhinocerotis, Moschus, Ganoderma spore powder and lotus leaf drink are mixed and add water to be decocted, repeatedly decoct three times, each 7～9h that decocts, during each the decoction, the addition of water is adds 3～6 times of the crude drug gross weight, decocting respectively resulting medicinal liquid by three times mixes, be concentrated into pasty state after mixing, obtain pasty medicament;
D, step c gained pasty medicament is added in the stand-by air-dry medicine of step b, mix homogeneously, air-dry, incapsulate the capsule of the tumor that obtains medical treatment after air-dry.
According to the medicine of above-mentioned treatment tumor, the specification of capsule described in steps d is every 0.4g.
The present invention treats the instructions of taking of the capsule of tumor: ante cibum or one after each meal, every day 3 times, each 5.
the pharmacological action of the various crude drug of the present invention:
Squama Manis: cold nature, salty in the mouth enter liver, stomach two warps.Effect: 1, dredging collateral is searched wind: this moral character is apt to away alter, and dredging collateral is searched wind, expelling wind and dampness, and through sick institute, with the joint insensitive impediment that disappears, stiff distortion.2, the eliminating carbuncle pus of bursting: this product promoting flow of QI and blood, dysmenorrhea dissipating blood stasis, and draw the product of heat clearing away, through sick institute, the person that do not become pus, disappear and loose it, the person that become pus, burst and thoroughly it.Pus of carbuncle will become the not machine of one-tenth, and that uses is the most suitable.3, active stimulating the menstrual flow: this product can the dispelling the stagnated QI promoting the circulation of blood, can walk to alter again row loose, and the gas clots absorbing is opened, and menses are descending.4, dredging collateral for promoting lactation.5,, Xiao Disorder eliminate indigestion: this product is salty-cold, can hard masses softening and resolving, can invigorate blood circulation by dredging collateral again, and it is loose that merit specially walks to alter row, and the priming sick institute that goes directly, therefore the use of You Xiao Disorder eliminate indigestion, eliminating stagnation.
Squama Manis preparata: get the Squama Manis sheet of choosing clean, size separately, separately put sand or Pulvis Talci in pot and fry to easily, adds the Squama Manis sheet, fries to heaving while being golden yellow, takes out, and sieve shakeout or Pulvis Talci, cool.
Poria: property is flat, and sweet in the mouth, light, enter the heart, spleen, lung, bladder, three warmers, stomach the six channels.Effect: 1, eliminating dampness and diuresis: this product diuretic and not feeling frustrated, the property of medicine is gentle, is the promoting diuresis to eliminate damp pathogen key medicine.Availablely control dysuria, edema, quench one's thirst, the card such as stranguria with turbid discharge.2, invigorating the spleen and regulating the stomach: the spleen invigorating of this product energy, for demonstrate,proving a little less than insufficiency of the spleen stomach, the available lack of appetite of controlling, loose stool, phlegm retention cough with dyspnea, the dizzy card that waits.3, mind tranquilizing and the heart calming: this product is sweet light, enters the heart, spleen, kidney channel.Can be used for deficiency of both the heart and spleen, all cards of the irritability of disarmony between the heart and kidney.4, strong lean marrow: the tonification of the sweet energy of this product specially enters spleen channel.Invigorating the spleen and replenishing QI, the secret vital essence of spleen invigorating, insufficiency of the spleen must the benefit, essence is closed to such an extent that solid seminal emission can stop.
Rhizoma Chuanxiong: warm in nature, acrid in the mouth, hardship; Enter liver, gallbladder, bladder, tri-jiao channel.Effect: 1, activating QI to alleviate the depression: this product suffering and gas perfume (or spice), benefaction is loose, the cloudy Liver Channel that enters to faint, soothing the liver strongly fragrant, promoting the circulation of QI to relieve pain, be usually used in distending pain in the chest and hypochondrium, the cards such as epigastric distending pain.2, dispeiling pathogenic wind and removing dampness: this product suffering can be manageed it loose, and fragrance is bitter dry, and expelling wind and cold and dampness, often can be used for the cards such as anemofrigid cold, anemofrigid-damp arthralgia, headche due to wind-cold.3, promoting blood circulation and stopping pain: this product is gas medicine in blood, and merit is arrogated to oneself promoting flow of QI and blood, antalgic.Often can be used for the cards such as puerperal blood faints, puerperal abdonimal pain, blood stasis amenorrhea.4, detumescence and apocenosis: this product promoting blood circulation and detumescence, the evacuation of pus tissue regeneration promoting, can be used for carbuncle, the cards such as treating swelling and pain by traumatic injury.
The Radix Paeoniae Alba: claim again Radix Paeoniae Alba, cold nature, bitter in the mouth, acid, enter liver, spleen two warps.Effect: 1, nourishing blood to suppress the hyperactive liver: this product bitter in the mouth, acid, enter Liver Channel, can tonifying liver blood and easing the affected liver.Be usually used in the cards such as menoxenia, dysmenorrhea.2, astringing YIN to stop sweating: this product picric acid, can nourish blood and seek, thus the energy astringing YIN to stop sweating, the cards such as spontaneous perspiration commonly used, night sweat, yellowish perspiration.3, pain relieving in slow: this product picric acid, be slightly cold, enter liver spleen two warps, can nourishing blood to suppress the hyperactive liver and relieving spasm to stop pain.Be usually used in stomachache, hypochondriac pain, have a stomachache, have loose bowels, the card such as dysentery.4, suppressing liver-YANG: this product is bitter can nourishing YIN, and acid can restrain, enters again Liver Channel, and the loose evil of liver libido is held back, therefore the energy suppressing liver-YANG is usually used in the card of excessive rising of liver-YANG.
Radix Angelicae Sinensis: warm in nature, acrid in the mouth, sweet; Enter the heart, liver, spleen, lung four warps.Effect: 1, nourshing blood and promoting blood circulation: this product sweet in the mouth and weighing, therefore specially can enrich blood, its gas is light and hot, again can promoting the circulation of blood, invigorating middle warmer has, in row, benefit is arranged, the sincere gas medicine in blood, also the panacea in blood is also.This product is good hematonic, therefore be applicable to the various syndromes that blood deficiency causes.2, promoting blood circulation and stopping pain: Radix Angelicae Sinensis can pursue congestion, and tissue regeneration promoting blood makes unobstructed vessel and gas parallel, flows round without stopping.Be usually used in traumatic injury stasis of blood pain, carbuncle stasis pain, the stagnant stomachache of the stasis of blood in puerperal, the card such as rheumatic arthralgia and meridians are unfavorable, this product has good promoting blood circulation and stopping pain effect.3, nourishing blood for regulating menstruation.4, loosening bowel to relieve constipation: few for blood deficiency Tianjin, the dryness of the intestine constipation.Disease is seen: constipation, and lusterless complexion, severe palpitation, have a dizzy spell.5, sending down the abnormal ascending QI cough-relieving: the hot temperature of Radix Angelicae Sinensis, enter lung meridian, depressed lung-energy dispersing is arranged, the merit of sending down the abnormal ascending QI cough-relieving.6, Radix Angelicae Sinensis should be for headache due to deficiency of blood and headache due to blood stasis person.
Chinese angelica blood supplementing is invigorated blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.For blood deficiency and yellow complexion, dizzy cardiopalmus, menoxenia, amenorrhea dysmenorrhea, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, injury from falling down, ulcer sores.
Venenum Bufonis: warm in nature, sweet in the mouth, suffering, poisonous; Enter stomach, the heart, kidney three warps.Effect: 1, removing toxic substances and promoting subsidence of swelling: but the sweet emergency of this product, and Xin Nenghang is loose, treating the poisonous disease with poisonous drugs, the merit of the removing toxic substances and promoting subsidence of swelling that tool is stronger, available carbuncle furuncle, the cards such as laryngopharynx swelling and pain controlled.2, pain relieving is had one's ideas straightened out: but the sweet relieving spasm to stop pain of this product, and Xin Wen disperses logical closing, and the double effect of having one's ideas straightened out of good pain relieving is arranged, and can be used for the diseases such as acute filthy disease, toothache.
Cornu rhinocerotis: claim again Cornu rhinocerotis, cold in nature, salty in the mouth, hardship; Enter the heart, liver, stomach three warps.Effect: heat clearing away arresting convulsion: this product clearing up internal heat by using drugs of bitter in taste and cold in nature, saltyly enter blood system, the fire of kind liver stomach three warps that clear away heart-fire, be the medicine dedicated of Xie Yingfen, noxious heat in the blood system.Therefore epidemic febrile disease caused by exogenous pathogens, intense heat in both QI and blood systems, intenseness of heat wind symptom etc., the merit that the heat clearing away arresting convulsion is arranged of using.2, removing pathogenic heat from blood and toxic substance from the body: this product is joined the army into blood, take the pyretic toxicity of cool solution blood system as long, therefore available treatment heat is burnt, battalion is cloudy, and heat is given birth to forcing blood, hot carbuncle toxin, and the heresies such as bloody dysentery enter nutrient blood, the card of the absurd row of forcing blood.3, detoxification sore treatment.
Moschus: warm in nature, acrid in the mouth enters the heart, spleen, liver three warps.Effect: 1, the refreshment of having one's ideas straightened out: the hot perfume (or spice) of this product is walked to alter, and can enter the heart and open and close to have one's ideas straightened out, to exorcise evil spirits, and coma is returned to normal, and the stronger logical power of closing of having one's ideas straightened out is arranged, and is refreshment analepsia key medicine.The excess syndrome of stroke such as all apoplexy, syncope due to accumulation of phlegm, infantile convulsion, unconsciousness due to high fever, see locked mouth arranged, hold, arteries and veins is strong etc., all available this product is with emergency.2, the dredging collateral of passing through: the hot loose temperature of this product is logical, fragrance is walked to alter, and 12 warps that can pass through have the merit of the dredging collateral of passing through, and can be used for the cards such as amenorrhea ， mass in the abdomen due to blockage of meridian.3, promoting blood circulation and stopping pain: the hot loose temperature of this product is logical, both adjustable mechanism of qi the meridian dredging, and that again can promoting the circulation of blood divides is stagnant with the dissipating blood stasis knot, has the merit of blood circulation promoting and dispersing pathogen accumulation, reducing swelling and alleviating pain.To swollen ulcer drug, the diseases such as traumatic injury, it is knowingly followed the example of a wrongdoer for significantly, is one of surgery good medicine.4, the lower tire of hastening parturition: its fragrant virtue of this product is strong, kindly can walk to alter and the key of being open to the custom; 12 warps that in addition can pass through again, the merit of tool promoting the circulation of QI to relieve pain, blood circulation promoting and dispersing pathogen accumulation; Therefore expedite the emergence of lower tire effect, to married woman's difficult labour, the cards such as retention of placenta, retention of dead fetus, all can apply.5, parasite killing removing toxic substances: the hot warm micro-hardship of this product, fragrance virtue are strong.Hot fragrant anthelmintic, uninteresting parasite killing, therefore this product is for oral administration, have the power of the Enterozoa of killing; Again because of this product can be open to the custom key, promoting flow of QI and blood, the eliminating stagnation of stimulating the menstrual flow, therefore the also merit of all insect poison of prodigiosin system.
The main effect that Ganoderma spore powder has is as follows:
1, antitumaous effect:
Ganoderma spore powder has obvious inhibitory action to kinds of tumor cells.For coordinating radiotherapy, the chemotherapy of malignant tumor patient, can strengthen patient's toleration, alleviate side effect, improve hemopoietic function of bone marrow, increase leukocytic transfer, recurrence, strengthen immunocompetence, promote rehabilitation.But patient with advanced cancer take after health invigorating and anti-cancer ability, alleviate generation and the development of complication, extend survival period, improve the quality of living.
2, Cardiovarscular:
Ganoderma spore powder has the effect to the blood pressure two-ways regulation; it is the diastole coronary artery blood flow effectively; improve microcirculation; increase myocardial oxygen delivery, purify the blood, reduce Blood Cholesterol and neutral fat content; prevent and dissolve the thrombosis in blood vessel; blood circulation promoting, have protective effect to acute myocardial ischemia, can reduce the formation of atheromatous plaque.For diseases such as coronary heart diseases and angina pectoris, arteriosclerosis, hypertension, hyperlipidemia, there is prevention and auxiliary therapeutic action preferably.
3, treatment digestive system disease:
Ganoderma spore powder has the protecting liver and detoxication function, can promote the metabolism of liver to medicine, poisonous substance, improves the regeneration capacity of liver, effectively improves liver function.Can improve the pancreas blood circulation, improve the pancreas physiological function, reduce blood glucose.The metabolism of energy facilitating digestion system.The diseases such as hepatitis, gastritis, gastric and duodenal ulcers, diabetes, chronic renal failure are had to obvious therapeutical effect.
4, treatment respiratory system disease:
Ganoderma spore powder has spasmolytic, the antiasthmatic effect ，Neng town bones of the body, eliminates the phlegm the organ smooth muscle, all effective in cure for chronic bronchitis and bronchial asthma etc.
5, treatment nervous system disease:
Ganoderma spore powder has regulating action to the central nervous system, effect stable, calm, pain relieving is arranged, for the neurasthenia with Yin nervous, the overtired insomnia caused, dizziness, weak, gastrointestinal dysfunction, forgetful, inappetence, have palpitation, breathe hard, the symptom such as hyperhidrosis is improved effect.
6, improve the human immunologic function:
Ganoderma spore powder can improve the function of cellular immunization and two aspects of humoral immunization, promote leukocyte to increase, improve the content of immunoglobulin and complement, the generation of inducing interferon, activate the activity of natural killer cell and macrophage, strengthen the weight of immune organ thymus, spleen, liver, thereby strengthen the resistivity of human body to various diseases.
7, defying age:
Ganoderma spore powder can be eliminated the interior free radical of body, stops lipid peroxidation, Cell protection, and the division algebraically of prolongation passage cell, promote cell survival, promotes metabolism, health invigorating, thereby effective slow down aging, but long-term taking life prolonging.
Lignum Aquilariae Resinatum: warm in nature, acrid in the mouth, hardship; Enter kidney, spleen, stomach three warps.Effect: 1, promoting the circulation of QI to relieve pain: the hot fragrant temperature of this product is logical, temperature and not dry, and row and not letting out, and good promoting the circulation of QI to relieve pain effect is arranged.Therefore, with controlling abdominal distention, all cards of traumatic injury are very imitated.2, during sending down the abnormal ascending QI is adjusted: this quality resedimentation, the fragrant liter of gas fallen apart.Enter the taste warp, easing stomach-QI, rise temper, warm in nature and not dry, benefaction and not letting out.During sending down the abnormal ascending QI is adjusted, the kind Deficiency and coldness of spleen and stomach of controlling, lifting imbalance, vomiting constipation.3, restoring normal coordination between the heart and kidney: this quality weighs and falls, and Xin Xiang master's liter, both risen and fallen, restoring normal coordination between the heart and kidney, and the extreme misery that both helped, therefore cure mainly it.4, the kidney warming improving inspiration by invigorating kidney-QI: this product sedimentation has the merit that improving inspiration by invigorating kidney-QI is returned unit, the dyspnea and cough due to deficiency of the kidney of controlling commonly used.This product temperature and not dry, row and not letting out, reach kidney and lead fire and return unit, the merit of sending down the abnormal ascending QI arranged, without the evil of dispelling the stagnated QI, therefore for controlling the good medicine of dyspnea and cough due to deficiency of the kidney.5, the warm essence of the kidney warming: the invigorating kidney-YANG of this product temperature, warm lean liquid.6, tonifying YANG eliminating impediment: the pure sun of this product and rising, body weight and falling, acrid in the mouth is wandered away, and the gas hero is walked crosswise, therefore exceedingly high ability merit is arranged, replenishing vital QI with drugs of warm nature internal organs, relaxing muscles and tendons and activating QI and blood in the collateral, function tonifying YANG eliminating impediment.
Rhizoma Cyperi: be sedge, the dry root footpath of dried tuber, excavate autumn, sing the hair must, put in boiling water slightly boil or steam after dry living use, but also processed with vinegar use.This moral character is hot, flat, and mildly bitter flavor, sweet, return liver, spleen, tri-jiao channel.Effect: the effect that this product has dispersing the stagnated live-QI to relieve the stagnation of QI, menstruction regulating and pain relieving, regulates the flow of vital energy in adjusting.
Lotus leaf drink: there is clearing away summer-heat and eliminating dampness, rise and send out sliding sun, the effect of hemostasis.Commonly use and control diarrhea due to summer heat and dampness, dizzy, the aqueous vapor edema, thunder-headache, spit blood, epistaxis, metrorrhagia, have blood in stool, puerperal blood faints.
Herba Solani Nigri: cold in nature, bitter in the mouth, micro-sweet, slightly poisonous; Enter lung, liver, stomach three warps.Effect: 1, heat-clearing and toxic substances removing: this product bitter cold, the heat clearing away of cold energy, the eliminating the pathogens from the lung of bitter energy, liver, stomach three warps, therefore can heat-clearing and toxic substances removing.Be usually used in treating the cards such as furuncle, carbuncle, erysipelas.2, promoting blood circulation and detumescence: this product bitter cold, enter Liver Channel, enter blood system, therefore the energy promoting blood circulation and detumescence is usually used in treating erysipelas, scrofula traumatic injury etc.3, the spasmolytic of reducing phlegm: this product is bitter can drying dampness to eliminate phlegm, cold can heat clearing away.Enter removing heat from the liver of Liver Channel.Calm down Yin Re and moving liver-wind and spasmolytic.Therefore the merit of the spasmolytic of reducing phlegm is arranged, can be used for children's's ailment said due to cold or exposure, the diseases such as heat symptom-complex infantile convulsion.4, liver heat removing and eyesight improving: this product is cold in nature.Enter again Liver Channel, thus can removing heat from the liver and improving eyesight, can be used for the liver-fire wind heat and the diseases such as conjunctival congestion and swelling pain pterygium that cause.5, dispelling wind for relieving itching: this product bitter in the mouth, bitter energy dampness removing to stop itchin, this product can be invigorated blood circulation.This product treatment pruritus due to wind pathogen commonly used, scabies is itched bitterly, the cards such as day bleb eczema.
Herba Scutellariae Barbatae: property is flat, acrid in the mouth, micro-hardship; Enter the heart, lung, liver, kidney four warps.Effect: 1, heat-clearing and toxic substances removing: this product acrid in the mouth, micro-hardship, property is flat.Effect with heat-clearing and toxic substances removing, oral administration, but external.Both can separate insect poison, and also can antidote against snake bite, be the good merchantable brand of bactericidal antiphlogistic.Commonly use and control dysentery, laryngopharynx swelling and pain, innominate toxic swelling, jaundice, throat moth, snakebite, furuncle, lung abscess, the card such as carbuncle on the back, 2, hemostasis: this moral character is flat, the micro-hardship of acrid in the mouth, tool heat clearing away, blood stasis dispelling, the effect of hemostasis.Cards such as commonly using and control haematemesis, epistaxis, hematuria, have blood in stool.3, eliminating stasis to stop pain: this product acrid in the mouth, the property that hot tool is walked to alter, have and disperse, circulation of qi promoting, promoting the circulation of blood effect.Therefore can be used for the stagnation of QI that a variety of causes causes, expectorant is solidifying, the diseases such as blood stasis.Scrofula sucutaneous nodule, the cards such as globus hystericus controlled commonly used.4, promoting the circulation of QI to induce diuresis: this product acrid in the mouth, micro-hardship, the merit of tool promoting the circulation of QI to induce diuresis.Can be used for functional activity of QI being not smooth, the card stopped in muddy water.Stagnation of QI hypochondriac pain, tympanites, extensive abdominal edema, the cards such as sufficient puffy face controlled commonly used.
JIANZHONGXIAO: abnormal smells from the patient is sour and astringent, and micro-poison is arranged.Function cures mainly: 1, carbuncle, Canis familiaris L. sting.2, all toxic swellings.
The compatibility mechanism of prescription of the present invention: prescription compatibility of the present invention is rigorous, through sick place.Especially Squama Manis preparata, but dispelling toxicity, detoxicating kill and inhibition tumor cell, Yin Yang balancing, enhancing immunity; Venenum Bufonis, Moschus promote Squama Manis preparata kill tumor cell; The Moschus causing resuscitation with aromatic drugs, penetration power is strong, through sick place.Ganoderma spore powder has, and sympotoms caused by cold factors or apoplexy due to deficiency anticancer, that regulate immunity, anti-curing oncoma, Antileukopemia, raising human body add reality, and its body is anti-sending an expedition against not, thereby note adopting the agent of tonification or temperature compensation, even send an expedition against.Also easily select the medicine that abnormal smells from the patient is thinner, toxicity is less to treat.
Squama Manis preparata, Venenum Bufonis, Moschus, Ganoderma spore powder, Poria, Rhizoma Cyperi, Lignum Aquilariae Resinatum, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Rhizoma Chuanxiong in prescription of the present invention, the QI invigorating righting, blood circulation promoting and blood stasis dispelling, anticancer, press down cancer, kill cancer cell function.In side: Squama Manis preparata has powerful strengthening vital QI to eliminate pathogenic factors to body, and the traditional Chinese medical science thinks that the human righteousness contains heresy and can not invade, and can improve the leukocytic ability of having a liking for that gulps down.Venenum Bufonis kill cancer cell heat-clearing and toxic substances removing, treating the poisonous disease with poisonous drugs, but great mass of data proves Venenum Bufonis, Moschus kill cancer cell.Tumor patient is the interior yin and yang imbalance of body all, the vigour virtual loss, and the expectorant blood coagulation stasis of blood, the coalescent three kinds of Basic disease cause pathology of cancer poison, three kinds of factors are: void, the stasis of blood, poison.These three kinds of factors are interrelated, form vicious cycle in human body, finally cause the cancerous cell diffusion transfer, human life exhaustion.The traditional Chinese medical science thinks, the real disease that belongs to asthenia of tumor, have concurrently and gather, and doctor trained in Western medicine thinks that body immunity is main cause due to descending.The Ganoderma spore powder has stronger raising antibody mediated immunity function function.Japan experimental results show that: the anticancer rate of Ganoderma spore powder reaches 80～95%, and Several Kinds of Malignancy is had to significant curative effect as leukemia, esophageal carcinoma, gastric cancer, intestinal cancer, pulmonary carcinoma, hepatocarcinoma etc.The Ganoderma spore powder can be strengthened the body antitumaous effect containing the material of a kind of " glucosidase ", also contains the derivant of interferon---double stranded RNA, can enter its propagation of inhibition of cancer cell.In side, Poria, the Radix Paeoniae Alba, Radix Angelicae Sinensis, Rhizoma Chuanxiong are that SIWU TANG is enriched blood greatly, and blood circulation promoting and blood stasis dispelling, it is reported, are that a kind of broad spectrum activity is strangled the cancerous cell medicine, have the cancer effect of obvious inhibition telomerase activation.Lignum Aquilariae Resinatum, Rhizoma Cyperi, the effect of regulating the flow of vital energy, and adjust equilibrium between yin and yang effect in body, Cornu rhinocerotis clears away heart-fire through pyretic toxicity.
Full side has in a word: fill blood, and regulate yin-yang, blood circulation promoting and blood stasis dispelling, treating the poisonous disease with poisonous drugs, improve immunity of organisms, kill cancer cell anticancer value-added functionality.
positive beneficial effect of the present invention:
1, the various tumors of the applicable treatment of Chinese medicine composition of the present invention, cancer, for example: cerebroma, hepatocarcinoma, esophageal carcinoma, gastric cancer, skin carcinoma etc.Utilizing the various tumors of Drug therapy of the present invention, determined curative effect, facilitate inexpensively, safe and reliable, is a kind of good medicine for the treatment of tumor.
2, utilize the various tumors of Drug therapy of the present invention, it is evident in efficacy, and total effective rate reaches more than 90%.
utilize the present invention to treat the medicine of tumor and the clinical data of the various tumors of capsule for treating thereof:
(1), for many years, utilize capsule for treating patients with gliomas 16 examples of Chinese medicine composition of the present invention and preparation thereof, man's 11 examples, female's 5 examples, wherein minimal ages is 18 years old, maximum 82 years old age, 5 examples after operation, take 1 of capsule that the present invention the treats tumor example courses for the treatment of 7, take 2 of capsules that the present invention the treats tumor example courses for the treatment of 9, dead 1 example.Wherein in 16 routine patients with gliomas, cure 5 examples, produce effects 8 examples, invalid 2 examples, dead 1 example, its total effective rate is 81.25%.
The glioma model case:
1, Zhang, the female, people from Xixia County, Nanyang, morbidity in the time of 8 years old, disease is seen insomnia, headache, repeated cold, medical at local hospital, doubt as cerebroma, after turn the Wuhan PLA General Hospital and be diagnosed as congenital cerebral glioma through the expert, need operative treatment, expense is higher, because patient's family economic condition is poor, has abandoned operative treatment.Rear long-term taking analgesic, it is invalid over more than ten years, through Chinese and western medicine, to control for a long time.Come after being introduced here medical, according to patient's symptom, the therapeutic scheme of taking is: (instructions of taking is: one after each meal, every day 3 times, each 5, every capsules 0.4g to take the capsule preparations that the present invention treats tumor; It within 30 days, is 1 course for the treatment of; The raw material composition of this treatment tumor capsule refers to embodiment 2), after taking continuously 1 course for the treatment of, insomnia, headache transference cure, do cranium CT check, the tumor body disappears substantially, and does cranium CT check after taking continuously 1 course for the treatment of, tumor disappears fully, and recovery from illness is followed up a case by regular visits to 2 years without recurrence.
2, Zhao, the man, 62 years old now, Wu Liqiao people from town, Xixia County, Nanyang, the headache phenomenon in April, 2007 appears in the patient, when serious, goes into a coma, and spits out white foams, even shock, in the treatment of Xixia County's hospital, do nuclear-magnetism and be diagnosed as glioma.This county hospital and Shanghai large hospital and hospital general, the military region, Wuhan etc. all think that this tumor growth position can't perform the operation, and this patient have to abandon operative treatment.Introduce in February, 2008 through the people, comes here medical, and according to patient's situation, the therapeutic scheme of taking is: (instructions of taking is: one after each meal, every day 3 times, each 5, every capsules 0.4g to take the capsule preparations that the present invention treats tumor; It within 30 days, is 1 course for the treatment of; The raw material composition of this treatment tumor capsule refers to embodiment 8), after taking continuously 1 course for the treatment of, headache, tic symptom obviously alleviate, attack times is less, does the nuclear-magnetism inspection, and tumor is obviously dwindled, imitate more not square, and check after taking continuously 1 course for the treatment of, above-mentioned symptom disappears, and follows up a case by regular visits to 1 year without recurrence.
3, Peng so-and-so, female, 17 years old, Xi Ping town, Xixia County, Nanyang Tang Jiawan people from village, in March, 1989, the patient starts headache, the time have nauseating, press cold, fever etc. the medicine does no good in commune hospital, local town, after be brain CT, doubtful brain has occupying lesion, do again nuclear-magnetism and be diagnosed as cerebroma, with further checking again to hospital general, the military region, Wuhan, be diagnosed as: cerebral glioma, surgical resection therapy; The hands Headache, feel sick, dizzy, the poor symptom of appetite all disappears.Headache occurs again after June nineteen ninety, this patient was because of flu, feels sick, weak, the time insomnia is arranged, memory subtracts greatly, after Xixia County's hospital admission, doing the nuclear-magnetism inspection, think that operation is rear more than 1 year, is former cerebral glioma recurrence, fail to respond to any medical treatment, after to hospital general, the military region, Wuhan (the former hospital that performs an operation) again, look for former doctor medical, this doctor says: be the human glioma operation recurrence, can not perform the operation again, the suggestion expectant treatment.After being introduced, come here medical, according to conditions of patients, the therapeutic scheme of taking: (instructions of taking is: one after each meal, every day 3 times, each 5, every capsules 0.4g to allow this patient's trial edition invent the capsule for the treatment of tumor; It within 30 days, is 1 course for the treatment of; The raw material composition of this treatment tumor capsule refers to embodiment 12), after taking continuously 1 course for the treatment of, sx↓, do not vomit, and spirit takes a turn for the better, significant effective; After taking continuously 2 courses for the treatment of, above-mentioned symptom is eliminated, and does the atrophy of CT tumor body and loses, recovery from illness.
(2), for many years, utilize capsule for treating patients with uterine myoma 230 examples of Chinese medicine composition of the present invention and preparation thereof, obtain significant curative effect.Wherein minimal ages is 29 years old, maximum 67 years old age.
Criterion of therapeutical effect and therapeutic outcome thereof:
Recovery from illness: take 1 to 3 course for the treatment of of medicine of the present invention, muscular tumor all disappears.
Produce effects: take 1 to 3 course for the treatment of of medicine of the present invention, muscular tumor is obviously dwindled.
Invalid: take 1 to 3 course for the treatment of of medicine of the present invention, muscular tumor has no dwindles.
This is organized 230 patients with uterin leiomyoma patients and takes medicine of the present invention after 2 courses for the treatment of, 219 examples of fully recovering, and produce effects 9 examples, invalid 2 examples, total effective rate reaches 99.13%.
This group patients with uterine myoma is taken the method that the present invention treats the tumor capsule: one after each meal, every day 3 times, each 5, every capsules 0.4g; It within 50 days, is 1 course for the treatment of.
model case:
1, the king so-and-so, female, 38 years old, people from Xixia County, Nanyang, medical to the People's Hospital, Xixia County in May, 2006, disease is seen: yellowish complexion, become thin, malaise, readme: menstrual blood volume is large, general 10～15 days, be diagnosed as hysteromyoma 18 * 7cm by the People's Hospital, Xixia County B ultrasonic, take Western medicine invalid, the doctor allows operative treatment, the patient, because only having a girl, also wants to have two babies, and is reluctant operative treatment.After being introduced, come here medical, according to conditions of patients, the therapeutic scheme of employing is: (instructions of taking is one after each meal, every day 3 times, each 5, every capsules 0.4g to take the capsule that the present invention treats tumor; It within 50 days, is 1 course for the treatment of; The raw material of this treatment tumor capsule form refer to embodiment 20), take the present invention and treat the tumor capsule after 1 course for the treatment of, make B ultrasonic and show that the tumor body dwindles, and take continuously 1 course for the treatment of, menstruation is also normal, does B ultrasonic and shows that muscular tumor all disappears, recovery from illness, follow up a case by regular visits to 2 years without recurrence.
(3), for many years, utilize capsule for treating patients with digestive system neoplasms 196 examples of Chinese medicine composition of the present invention and preparation thereof, obtain significant curative effect.Male patient's 126 examples wherein, female patient's 70 examples, patient age is more than 50 years old.
Criterion of therapeutical effect and therapeutic outcome thereof:
Recovery from illness: take 1 to 3 course for the treatment of of medicine of the present invention, muscular tumor all disappears.
Produce effects: take 1 to 3 course for the treatment of of medicine of the present invention, muscular tumor is obviously dwindled.
Invalid: take 1 to 3 course for the treatment of of medicine of the present invention, muscular tumor has no dwindles.
This is organized 196 routine patients with digestive system neoplasms and takes medicine of the present invention after 2 courses for the treatment of, 126 examples of fully recovering, and produce effects 63 examples, invalid 7 examples, cure and reach 64.28%, and total effective rate reaches 96.42%.
This group patients with digestive system neoplasms is taken the method that the present invention treats the tumor capsule: bfore meals, and every day 3 times, each 5, every capsules 0.4g; It within 50 days, is 1 course for the treatment of.
model case:
1, Wang, man, 53 years old now, people from Xixia County, Nanyang, this patient makes a definite diagnosis chemical examination for mid and late liver cancer in April, 2003 through the People's Hospital, Xixia County B ultrasonic nuclear-magnetism, and to Beijing, the operation of filling a vacancy is done by 301 military hospitals, lives afterwards first quarter moon, medical expense is very high, and abdominal distention alleviated at that time, and the food drink also takes a turn for the better.Do not perform an operation the frequent pain in front hepatic region, abdominal distention, see greasyly do not want to eat, general weakness.Go to this year May Beijing to perform an operation, after half a year, above-mentioned card shape increases the weight of, and anemia, weak again, and body weight drops to 106 jin, yellowish complexion, off color by original 126 jin.Arrive again Henan Prov. Tumour Hospital's radiotherapy 25 times this year end of the year, each 900 yuan, feeling sick just appears in radiotherapy 10 times, abdominal distention, appetite subtract greatly, and some profits are not wanted to eat yet, and meat is not wanted to see yet, as weak as water.Radiotherapy finishes to come after being introduced here medical, according to conditions of patients, the therapeutic scheme of taking: allow this patient's trial edition invention treatment tumor capsule (instructions of taking is: bfore meals, every day 3 times, each 5, every capsules 0.4g; It within 50 days, is 1 course for the treatment of; The raw material composition of this treatment tumor capsule refers to embodiment 4), after taking continuously 2 courses for the treatment of, appetite increases, and whole body energetically, abdominal distention also obviously alleviates, and taken continuously 2 courses for the treatment of, stable disease, be liver CT, the tumor body narrows down to 1.2 * 0.8cm by original 10 * 9cm, and taken 1 course for the treatment of, to do B ultrasonic tumor body and eliminate, chemical examination liver function test index is all normal.
2, the king so-and-so, the man, 62 years old now, Yan Zhen people from village, stone boundary river township, Xixia County, Nanyang, in March, 2007 here medical, this patient's feed is at that time blocked and is felt more than February, often weak, appetite is poor, yellowish complexion, become thin, and in Xixia County institute of traditional Chinese medicine, does the esophageal barium meal perspective, doubts the esophagus occupying lesion, after make again gastroscope and do pathologic finding after, be diagnosed as hypomere cancer in esophagus.According to conditions of patients, the therapeutic scheme of taking is: take the capsule preparations that the present invention treats tumor (instructions of taking is: bfore meals, every day 3 times, each 5, every capsules 0.4g; It within 50 days, is 1 course for the treatment of; The raw material composition of this treatment tumor capsule refers to embodiment 14), after taking continuously 1 course for the treatment of, this patient has a meal and no longer blocks, and body weight increases, and spirit takes a favorable turn, can work, recovery from illness.
3, stone so-and-so, man, 72 years old now, carriage return town, Xixia County, Nanyang bulk ground people from village.This patient is diagnosed as the gastric cancer later stage in Qiu Jing Xixia County hospital in 2002, and companion's hepatic metastases.That this patient became thin at that time was weak, tell after food, anemia is dizzy, moving asthma, and hospital says that this patient has lost the surgical engine meeting, can only do the chemotherapy and radiation expectant treatment, is in a bad way, critically ill.Come after being introduced here medical, according to conditions of patients, the therapeutic scheme of taking is: take the capsule preparations that the present invention treats tumor (instructions of taking is: bfore meals, every day 3 times, each 5, every capsules 0.4g; It within 50 days, is 1 course for the treatment of; The raw material composition of this treatment tumor capsule refers to embodiment 17), take continuously stable disease after 2 courses for the treatment of, have a meal and do not tell, body weight also increases, and anemia also takes a turn for the better, not hematochrome 7 before clothes, blood test after two months, leukocyte is raised to more than 6,000 by original more than 2,000, and hematochrome is raised to 9 by 7, and liver B ultrasonic metastatic tumour has dwindled half.And take continuously the present invention and treat 2 courses for the treatment of of tumor capsule preparations, health is good, can eat and can sleep, in high spirits, is almost recovered.
4, Wang, the man, 52 years old now, village people, peasant were closed in field, Xixia County, Nanyang.Because of diet self-induction esophagus hypomere, the plug of blocking is arranged in May, 2003, make gastroscope in Xixia County hospital and be diagnosed as carcinoma of gastric cardia (late period).Because body constitution is good at ordinary times, family economical condition is better, requires operative treatment, and according to patient's situation, hospital will not perform the operation.Come after being introduced here medical, according to patient's situation, the therapeutic scheme of taking is: (instructions of taking is: one after each meal, every day 3 times, each 5, every capsules 0.4g to take the capsule preparations that the present invention treats tumor; It within 50 days, is 1 course for the treatment of; The raw material composition of this treatment tumor capsule refers to embodiment 1), after taking continuously 1 course for the treatment of, this patient has a meal without blocking sensation, imitates more not square, and, after taking continuously 1 course for the treatment of, patient's subjective symptoms takes a turn for the better, and does gastroscopy, gastric cardia tumor disappears, and body weight increases, and follows up a case by regular visits to 1 year without recurrence.
(4), for many years, utilize capsule for treating skin carcinoma patient 38 examples of Chinese medicine composition of the present invention and preparation thereof, obtain significant curative effect, total effective rate reaches more than 90%.
This group skin carcinoma patient takes the method that the present invention treats the tumor capsule: one after each meal, every day 3 times, each 5, every capsules 0.4g; It within 50 days, is 1 course for the treatment of.
four, the specific embodiment:
Further illustrate the present invention below in conjunction with embodiment, but do not limit content of the present invention.
Embodiment 1:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 200 parts of crude drug Squama Manis preparatas, 180 parts, Poria, 80 parts of Rhizoma Chuanxiongs, 100 parts of the Radix Paeoniae Albas, 60 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss, 3 parts of Cornu rhinocerotis, 3 parts, Moschus, 180 parts of Ganoderma spore powders, 30 parts of Lignum Aquilariae Resinatum, 2000 parts of 80 parts of Rhizoma Cyperi and lotus leaf drinks are made.
The dosage form that the present invention treats the medicine of tumor is capsule.The preparation method of its capsule is:
A, at first the crude drug proportioning ratio according to above-mentioned medicine for treating tumor thing takes various crude drug;
B, crude drug Venenum Bufonis, Cornu rhinocerotis and the Moschus taken added in lotus leaf drink and carry out mixed grinding, grind and make emulsus, then it is air-dry to add the crude drug Ganoderma spore powder to carry out, obtain air-dry medicine after air-dry stand-by;
C, other crude drug except Venenum Bufonis, Cornu rhinocerotis, Moschus, Ganoderma spore powder and lotus leaf drink are mixed and add water to be decocted, repeatedly decoct three times, each 7～9h that decocts, during each the decoction, the addition of water is adds 3～6 times of the crude drug gross weight, decocting respectively resulting medicinal liquid by three times mixes, be concentrated into pasty state after mixing, obtain pasty medicament;
D, step c gained pasty medicament is added in the stand-by air-dry medicine of step b, mix homogeneously, air-dry, incapsulate the capsule of the tumor that obtains medical treatment (specification of prepared capsule is every 0.4g) after air-dry.
Embodiment 2: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 220 parts of crude drug Squama Manis preparatas, 210 parts, Poria, 90 parts of Rhizoma Chuanxiongs, 130 parts of the Radix Paeoniae Albas, 90 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss, 4 parts of Cornu rhinocerotis, 4 parts, Moschus, 200 parts of Ganoderma spore powders, 35 parts of Lignum Aquilariae Resinatum, 2300 parts of 100 parts of Rhizoma Cyperi and lotus leaf drinks are made.
Embodiment 3: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 250 parts of crude drug Squama Manis preparatas, 250 parts, Poria, 100 parts of Rhizoma Chuanxiongs, 150 parts of the Radix Paeoniae Albas, 120 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss, 5 parts of Cornu rhinocerotis, 5 parts, Moschus, 220 parts of Ganoderma spore powders, 40 parts of Lignum Aquilariae Resinatum, 2500 parts of 120 parts of Rhizoma Cyperi and lotus leaf drinks are made.
Embodiment 4: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 210 parts of crude drug Squama Manis preparatas, 230 parts, Poria, 85 parts of Rhizoma Chuanxiongs, 120 parts of the Radix Paeoniae Albas, 70 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss, 4 parts of Cornu rhinocerotis, 4 parts, Moschus, 190 parts of Ganoderma spore powders, 32 parts of Lignum Aquilariae Resinatum, 2250 parts of 110 parts of Rhizoma Cyperi and lotus leaf drinks are made.
Embodiment 5: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 240 parts of crude drug Squama Manis preparatas, 190 parts, Poria, 95 parts of Rhizoma Chuanxiongs, 110 parts of the Radix Paeoniae Albas, 100 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss, 5 parts of Cornu rhinocerotis, 3 parts, Moschus, 210 parts of Ganoderma spore powders, 36 parts of Lignum Aquilariae Resinatum, 2350 parts of 90 parts of Rhizoma Cyperi and lotus leaf drinks are made.
Embodiment 6: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 230 parts of crude drug Squama Manis preparatas, 200 parts, Poria, 98 parts of Rhizoma Chuanxiongs, 140 parts of the Radix Paeoniae Albas, 110 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss, 3 parts of Cornu rhinocerotis, 5 parts, Moschus, 200 parts of Ganoderma spore powders, 35 parts of Lignum Aquilariae Resinatum, 2400 parts of 100 parts of Rhizoma Cyperi and lotus leaf drinks are made.
Embodiment 7: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 200 parts of crude drug Squama Manis preparatas, 180 parts, Poria, 80 parts of Rhizoma Chuanxiongs, 100 parts of the Radix Paeoniae Albas, 60 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss, 3 parts of Cornu rhinocerotis, 3 parts, Moschus, 180 parts of Ganoderma spore powders, 30 parts of Lignum Aquilariae Resinatum, 80 parts of Rhizoma Cyperi, 60 parts of Herba Solani Nigris, 2000 parts of 30 parts of xyloid stem of Flos Helianthi and lotus leaf drinks are made.
Embodiment 8: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 220 parts of crude drug Squama Manis preparatas, 210 parts, Poria, 90 parts of Rhizoma Chuanxiongs, 130 parts of the Radix Paeoniae Albas, 90 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss, 4 parts of Cornu rhinocerotis, 4 parts, Moschus, 200 parts of Ganoderma spore powders, 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi, 80 parts of Herba Solani Nigris, 2300 parts of 40 parts of xyloid stem of Flos Helianthi and lotus leaf drinks are made.
Embodiment 9: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 250 parts of crude drug Squama Manis preparatas, 250 parts, Poria, 100 parts of Rhizoma Chuanxiongs, 150 parts of the Radix Paeoniae Albas, 120 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss, 5 parts of Cornu rhinocerotis, 5 parts, Moschus, 220 parts of Ganoderma spore powders, 40 parts of Lignum Aquilariae Resinatum, 120 parts of Rhizoma Cyperi, 100 parts of Herba Solani Nigris, 2500 parts of 50 parts of xyloid stem of Flos Helianthi and lotus leaf drinks are made.
Embodiment 10: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 210 parts of crude drug Squama Manis preparatas, 230 parts, Poria, 85 parts of Rhizoma Chuanxiongs, 120 parts of the Radix Paeoniae Albas, 70 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss, 4 parts of Cornu rhinocerotis, 4 parts, Moschus, 190 parts of Ganoderma spore powders, 32 parts of Lignum Aquilariae Resinatum, 110 parts of Rhizoma Cyperi, 70 parts of Herba Solani Nigris, 2250 parts of 35 parts of xyloid stem of Flos Helianthi and lotus leaf drinks are made.
Embodiment 11: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 240 parts of crude drug Squama Manis preparatas, 190 parts, Poria, 95 parts of Rhizoma Chuanxiongs, 110 parts of the Radix Paeoniae Albas, 100 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss, 5 parts of Cornu rhinocerotis, 3 parts, Moschus, 210 parts of Ganoderma spore powders, 36 parts of Lignum Aquilariae Resinatum, 90 parts of Rhizoma Cyperi, 90 parts of Herba Solani Nigris, 2350 parts of 45 parts of xyloid stem of Flos Helianthi and lotus leaf drinks are made.
Embodiment 12: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 230 parts of crude drug Squama Manis preparatas, 200 parts, Poria, 98 parts of Rhizoma Chuanxiongs, 140 parts of the Radix Paeoniae Albas, 110 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss, 3 parts of Cornu rhinocerotis, 5 parts, Moschus, 200 parts of Ganoderma spore powders, 35 parts of Lignum Aquilariae Resinatum, 80 parts of 100 portions of Herba Solani Nigris of Rhizoma Cyperi, 2400 parts of 42 parts of xyloid stem of Flos Helianthi and lotus leaf drinks are made.
Embodiment 13:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 200 parts of crude drug Squama Manis preparatas, 180 parts, Poria, 80 parts of Rhizoma Chuanxiongs, 100 parts of the Radix Paeoniae Albas, 60 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss, 3 parts of Cornu rhinocerotis, 3 parts, Moschus, 180 parts of Ganoderma spore powders, 30 parts of Lignum Aquilariae Resinatum, 80 parts of Rhizoma Cyperi, 2000 parts of 80 parts of Herba Scutellariae Barbataes and lotus leaf drinks are made.
Embodiment 14: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 220 parts of crude drug Squama Manis preparatas, 210 parts, Poria, 90 parts of Rhizoma Chuanxiongs, 130 parts of the Radix Paeoniae Albas, 90 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss, 4 parts of Cornu rhinocerotis, 4 parts, Moschus, 200 parts of Ganoderma spore powders, 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi, 2300 parts of 100 parts of Herba Scutellariae Barbataes and lotus leaf drinks are made.
Embodiment 15: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 250 parts of crude drug Squama Manis preparatas, 250 parts, Poria, 100 parts of Rhizoma Chuanxiongs, 150 parts of the Radix Paeoniae Albas, 120 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss, 5 parts of Cornu rhinocerotis, 5 parts, Moschus, 220 parts of Ganoderma spore powders, 40 parts of Lignum Aquilariae Resinatum, 120 parts of Rhizoma Cyperi, 2500 parts of 120 parts of Herba Scutellariae Barbataes and lotus leaf drinks are made.
Embodiment 16: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 210 parts of crude drug Squama Manis preparatas, 230 parts, Poria, 85 parts of Rhizoma Chuanxiongs, 120 parts of the Radix Paeoniae Albas, 70 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss, 4 parts of Cornu rhinocerotis, 4 parts, Moschus, 190 parts of Ganoderma spore powders, 32 parts of Lignum Aquilariae Resinatum, 110 parts of Rhizoma Cyperi, 2250 parts of 90 parts of Herba Scutellariae Barbataes and lotus leaf drinks are made.
Embodiment 17: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 240 parts of crude drug Squama Manis preparatas, 190 parts, Poria, 95 parts of Rhizoma Chuanxiongs, 110 parts of the Radix Paeoniae Albas, 100 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss, 5 parts of Cornu rhinocerotis, 3 parts, Moschus, 210 parts of Ganoderma spore powders, 36 parts of Lignum Aquilariae Resinatum, 90 parts of Rhizoma Cyperi, 2350 parts of 110 parts of Herba Scutellariae Barbataes and lotus leaf drinks are made.
Embodiment 18: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 230 parts of crude drug Squama Manis preparatas, 200 parts, Poria, 98 parts of Rhizoma Chuanxiongs, 140 parts of the Radix Paeoniae Albas, 110 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss, 3 parts of Cornu rhinocerotis, 5 parts, Moschus, 200 parts of Ganoderma spore powders, 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi, 2400 parts of 105 parts of Herba Scutellariae Barbataes and lotus leaf drinks are made.
Embodiment 19:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 200 parts of crude drug Squama Manis preparatas, 180 parts, Poria, 80 parts of Rhizoma Chuanxiongs, 100 parts of the Radix Paeoniae Albas, 60 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss, 3 parts of Cornu rhinocerotis, 3 parts, Moschus, 180 parts of Ganoderma spore powders, 30 parts of Lignum Aquilariae Resinatum, 80 parts of Rhizoma Cyperi, 2000 parts of 100 parts of JIANZHONGXIAO and lotus leaf drinks are made.
Embodiment 20: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 220 parts of crude drug Squama Manis preparatas, 210 parts, Poria, 90 parts of Rhizoma Chuanxiongs, 130 parts of the Radix Paeoniae Albas, 90 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss, 4 parts of Cornu rhinocerotis, 4 parts, Moschus, 200 parts of Ganoderma spore powders, 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi, 2300 parts of 130 parts of JIANZHONGXIAO and lotus leaf drinks are made.
Embodiment 21: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 250 parts of crude drug Squama Manis preparatas, 250 parts, Poria, 100 parts of Rhizoma Chuanxiongs, 150 parts of the Radix Paeoniae Albas, 120 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss, 5 parts of Cornu rhinocerotis, 5 parts, Moschus, 220 parts of Ganoderma spore powders, 40 parts of Lignum Aquilariae Resinatum, 120 parts of Rhizoma Cyperi, 2500 parts of 150 parts of JIANZHONGXIAO and lotus leaf drinks are made.
Embodiment 22: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 210 parts of crude drug Squama Manis preparatas, 230 parts, Poria, 85 parts of Rhizoma Chuanxiongs, 120 parts of the Radix Paeoniae Albas, 70 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss, 4 parts of Cornu rhinocerotis, 4 parts, Moschus, 190 parts of Ganoderma spore powders, 32 parts of Lignum Aquilariae Resinatum, 110 parts of Rhizoma Cyperi, 2250 parts of 120 parts of JIANZHONGXIAO and lotus leaf drinks are made.
Embodiment 23: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 240 parts of crude drug Squama Manis preparatas, 190 parts, Poria, 95 parts of Rhizoma Chuanxiongs, 110 parts of the Radix Paeoniae Albas, 100 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss, 5 parts of Cornu rhinocerotis, 3 parts, Moschus, 210 parts of Ganoderma spore powders, 36 parts of Lignum Aquilariae Resinatum, 90 parts of Rhizoma Cyperi, 2350 parts of 110 parts of JIANZHONGXIAO and lotus leaf drinks are made.
Embodiment 24: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 230 parts of crude drug Squama Manis preparatas, 200 parts, Poria, 98 parts of Rhizoma Chuanxiongs, 140 parts of the Radix Paeoniae Albas, 110 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss, 3 parts of Cornu rhinocerotis, 5 parts, Moschus, 200 parts of Ganoderma spore powders, 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi, 2400 parts of 140 parts of JIANZHONGXIAO and lotus leaf drinks are made.
Embodiment 25:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 200 parts of crude drug Squama Manis preparatas, 180 parts, Poria, 80 parts of Rhizoma Chuanxiongs, 100 parts of the Radix Paeoniae Albas, 60 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss, 3 parts of Cornu rhinocerotis, 3 parts, Moschus, 180 parts of Ganoderma spore powders, 30 parts of Lignum Aquilariae Resinatum, 80 parts of Rhizoma Cyperi, 3 of animal spleen are made with 2000 parts of lotus leaf drinks.
Embodiment 26: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 220 parts of crude drug Squama Manis preparatas, 210 parts, Poria, 90 parts of Rhizoma Chuanxiongs, 130 parts of the Radix Paeoniae Albas, 90 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss, 4 parts of Cornu rhinocerotis, 4 parts, Moschus, 200 parts of Ganoderma spore powders, 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi, 3 of animal spleen are made with 2300 parts of lotus leaf drinks.
Embodiment 27: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 250 parts of crude drug Squama Manis preparatas, 250 parts, Poria, 100 parts of Rhizoma Chuanxiongs, 150 parts of the Radix Paeoniae Albas, 120 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss, 5 parts of Cornu rhinocerotis, 5 parts, Moschus, 220 parts of Ganoderma spore powders, 40 parts of Lignum Aquilariae Resinatum, 120 parts of Rhizoma Cyperi, 3 of animal spleen are made with 2500 parts of lotus leaf drinks.
Embodiment 28: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 210 parts of crude drug Squama Manis preparatas, 230 parts, Poria, 85 parts of Rhizoma Chuanxiongs, 120 parts of the Radix Paeoniae Albas, 70 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss, 4 parts of Cornu rhinocerotis, 4 parts, Moschus, 190 parts of Ganoderma spore powders, 32 parts of Lignum Aquilariae Resinatum, 110 parts of Rhizoma Cyperi, 3 of animal spleen are made with 2250 parts of lotus leaf drinks.
Embodiment 29: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 240 parts of crude drug Squama Manis preparatas, 190 parts, Poria, 95 parts of Rhizoma Chuanxiongs, 110 parts of the Radix Paeoniae Albas, 100 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss, 5 parts of Cornu rhinocerotis, 3 parts, Moschus, 210 parts of Ganoderma spore powders, 36 parts of Lignum Aquilariae Resinatum, 90 parts of Rhizoma Cyperi, 3 of animal spleen are made with 2350 parts of lotus leaf drinks.
Embodiment 30: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of tumor, with weight portion, means, the drug main of described treatment tumor will be by 230 parts of crude drug Squama Manis preparatas, 200 parts, Poria, 98 parts of Rhizoma Chuanxiongs, 140 parts of the Radix Paeoniae Albas, 110 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss, 3 parts of Cornu rhinocerotis, 5 parts, Moschus, 200 parts of Ganoderma spore powders, 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi, 3 of animal spleen are made with 2400 parts of lotus leaf drinks.
Claims (1)
1. a medicine for the treatment of tumor, it is characterized in that: with weight portion, mean, the medicine material medicine of described treatment tumor is 200～250 parts of Squama Manis preparatas, 180～250 parts, Poria, 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss, 3～5 parts of Cornu rhinocerotis, 3～5 parts, Moschus, 180～220 parts of Ganoderma spore powders, 30～40 parts of Lignum Aquilariae Resinatum, 2000～2500 parts of 80～120 parts of Rhizoma Cyperi and lotus leaf drinks are made.
2. a medicine for the treatment of tumor, it is characterized in that: with weight portion, mean, the medicine material medicine of described treatment tumor is 200～250 parts of Squama Manis preparatas, 180～250 parts, Poria, 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss, 3～5 parts of Cornu rhinocerotis, 3～5 parts, Moschus, 180～220 parts of Ganoderma spore powders, 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi, 60～100 parts of Herba Solani Nigris, 2000～2500 parts of 30～50 parts of xyloid stem of Flos Helianthi and lotus leaf drinks are made.
3. a medicine for the treatment of tumor, it is characterized in that: with weight portion, mean, the medicine material medicine of described treatment tumor is 200～250 parts of Squama Manis preparatas, 180～250 parts, Poria, 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss, 3～5 parts of Cornu rhinocerotis, 3～5 parts, Moschus, 180～220 parts of Ganoderma spore powders, 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi, 2000～2500 parts of 80～120 parts of Herba Scutellariae Barbataes and lotus leaf drinks are made.
4. a medicine for the treatment of tumor, it is characterized in that: with weight portion, mean, the medicine material medicine of described treatment tumor is 200～250 parts of Squama Manis preparatas, 180～250 parts, Poria, 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss, 3～5 parts of Cornu rhinocerotis, 3～5 parts, Moschus, 180～220 parts of Ganoderma spore powders, 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi, 2000～2500 parts of 100～150 parts of JIANZHONGXIAO and lotus leaf drinks are made.
5. according to the medicine of the described treatment tumor of claim 1～4 any one, it is characterized in that: the dosage form of the medicine of described treatment tumor is capsule.
6. the medicine for the treatment of tumor according to claim 5, is characterized in that, the preparation method of described capsule is:
A, at first the crude drug proportioning ratio according to the described medicine for treating tumor thing of claim 1～4 any one takes various crude drug;
B, crude drug Venenum Bufonis, Cornu rhinocerotis and the Moschus taken added in lotus leaf drink and carry out mixed grinding, grind and make emulsus, then it is air-dry to add the crude drug Ganoderma spore powder to carry out, obtain air-dry medicine after air-dry stand-by;
C, other crude drug except Venenum Bufonis, Cornu rhinocerotis, Moschus, Ganoderma spore powder and lotus leaf drink are mixed and add water to be decocted, repeatedly decoct three times, each 7～9h that decocts, during each the decoction, the addition of water is adds 3～6 times of the crude drug gross weight, decocting respectively resulting medicinal liquid by three times mixes, be concentrated into pasty state after mixing, obtain pasty medicament;
D, step c gained pasty medicament is added in the stand-by air-dry medicine of step b, mix homogeneously, air-dry, incapsulate the capsule of the tumor that obtains medical treatment after air-dry.
7. the medicine for the treatment of tumor according to claim 6, it is characterized in that: the specification of capsule described in steps d is every 0.4g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100123303A CN102552619B (en) | 2012-01-16 | 2012-01-16 | Medicine for treating tumor and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100123303A CN102552619B (en) | 2012-01-16 | 2012-01-16 | Medicine for treating tumor and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102552619A CN102552619A (en) | 2012-07-11 |
| CN102552619B true CN102552619B (en) | 2013-12-18 |
Family
ID=46400073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100123303A Expired - Fee Related CN102552619B (en) | 2012-01-16 | 2012-01-16 | Medicine for treating tumor and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102552619B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115192662A (en) * | 2022-03-25 | 2022-10-18 | 骆效黎 | Traditional Chinese medicine composition and medicine for treating tumors |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101172133A (en) * | 2007-10-17 | 2008-05-07 | 崔红彬 | Novel-generation tonic anticancer composite medicine |
| CN101664486A (en) * | 2008-09-05 | 2010-03-10 | 李世芳 | Chinese medicinal preparation for treating tumors |
| CN101869688A (en) * | 2010-06-11 | 2010-10-27 | 中山海济中药研发有限公司 | Chinese medicinal compound preparation for treating uterine myoma |
-
2012
- 2012-01-16 CN CN2012100123303A patent/CN102552619B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101172133A (en) * | 2007-10-17 | 2008-05-07 | 崔红彬 | Novel-generation tonic anticancer composite medicine |
| CN101664486A (en) * | 2008-09-05 | 2010-03-10 | 李世芳 | Chinese medicinal preparation for treating tumors |
| CN101869688A (en) * | 2010-06-11 | 2010-10-27 | 中山海济中药研发有限公司 | Chinese medicinal compound preparation for treating uterine myoma |
Non-Patent Citations (2)
| Title |
|---|
| 子宫肌瘤的中医药治疗及研究现状;蔡玉华等;《中国中医药信息杂志》;19991231;第6卷(第10期);第19-22页 * |
| 蔡玉华等.子宫肌瘤的中医药治疗及研究现状.《中国中医药信息杂志》.1999,第6卷(第10期),第19-22页. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102552619A (en) | 2012-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104288651A (en) | Medicine for treating postpartum hypogalactia and preparation method thereof | |
| CN104740546A (en) | Traditional Chinese medicine composition for treating gastric cancer | |
| CN105687409A (en) | Stone needle mud moxibustion and method for preparing same | |
| CN104069162A (en) | Traditional Chinese medicine for treating gouty arthritis and various bone and arthrosis pains | |
| CN102772693B (en) | Medicine for treating recurrent oral ulcer and preparation method thereof | |
| CN102552619B (en) | Medicine for treating tumor and preparation method thereof | |
| CN103212020A (en) | Traditional Chinese medicine composition for treating functional dyspepsia | |
| CN103705733B (en) | One treats ARR Chinese medicinal capsule and preparation method thereof | |
| CN105435190A (en) | Traditional Chinese medicine composition for treating cold-heat jumble asthma and preparation method of traditional Chinese medicine composition | |
| CN105233208A (en) | Traditional Chinese medicine preparation for treating heart failure | |
| CN104840874A (en) | Traditional Chinese medicine pills used for aneurysm postoperative rehabilitation treatment and preparation method thereof | |
| CN102949679A (en) | Medicine for curing lung cancer and preparation method thereof | |
| CN103933402A (en) | Traditional Chinese medicine preparation for treating brain tumor and preparation method | |
| CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
| CN103263628A (en) | Traditional Chinese medicine for treating diabetes | |
| CN103127398B (en) | Chinese medicament for treating cancers and preparation method thereof | |
| CN103908579A (en) | Spleen and stomach tonifying preparation for resisting side effects of chemotherapy and preparation method thereof | |
| CN104147166B (en) | Septicemia initial stage refreshing and detoxicating drink and method for making | |
| CN105250816A (en) | Medicine composition for treating phlegmatic hygrosis and preparation method and application of medicine composition | |
| CN104940777A (en) | Electuary capable of treating liver-yang hyperactivity and spleen weakness type diarrhea during menstruation and preparation method thereof | |
| CN105106712A (en) | Nutritional porridge capable of helping postoperative recovery of cancer patient and preparation method thereof | |
| CN104383245A (en) | Traditional Chinese medicine mixture for treating yin deficiency and yang excess type insomnia | |
| CN104138574A (en) | Traditional Chinese medicine decoction for treating tympanites of infants | |
| CN103720870A (en) | Traditional Chinese medicament preparation for treating myocarditis and preparation method thereof | |
| CN103505662A (en) | Baby mouse containing medicinal liquor formula |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131218 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |